- Home
- DHT vs BHVN Comparison
DHT vs BHVN Comparison
Compare DHT & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DHT
- BHVN
- Stock Information
- Founded
- DHT 2005
- BHVN 2013
- Country
- DHT Bermuda
- BHVN United States
- Employees
- DHT N/A
- BHVN N/A
- Industry
- DHT Marine Transportation
- BHVN Biotechnology: Pharmaceutical Preparations
- Sector
- DHT Consumer Discretionary
- BHVN Health Care
- Exchange
- DHT Nasdaq
- BHVN Nasdaq
- Market Cap
- DHT 1.6B
- BHVN 1.9B
- IPO Year
- DHT 2005
- BHVN 2017
- Fundamental
- Price
- DHT $10.42
- BHVN $20.37
- Analyst Decision
- DHT Strong Buy
- BHVN Strong Buy
- Analyst Count
- DHT 3
- BHVN 14
- Target Price
- DHT $13.67
- BHVN $63.15
- AVG Volume (30 Days)
- DHT 2.3M
- BHVN 1.7M
- Earning Date
- DHT 05-13-2025
- BHVN 05-08-2025
- Dividend Yield
- DHT 9.13%
- BHVN N/A
- EPS Growth
- DHT 13.13
- BHVN N/A
- EPS
- DHT 1.12
- BHVN N/A
- Revenue
- DHT $571,773,000.00
- BHVN N/A
- Revenue This Year
- DHT N/A
- BHVN N/A
- Revenue Next Year
- DHT $24.33
- BHVN $65.26
- P/E Ratio
- DHT $9.30
- BHVN N/A
- Revenue Growth
- DHT 2.00
- BHVN N/A
- 52 Week Low
- DHT $8.67
- BHVN $15.79
- 52 Week High
- DHT $12.80
- BHVN $55.70
- Technical
- Relative Strength Index (RSI)
- DHT 51.07
- BHVN 39.78
- Support Level
- DHT $9.86
- BHVN $15.79
- Resistance Level
- DHT $10.39
- BHVN $19.30
- Average True Range (ATR)
- DHT 0.45
- BHVN 2.20
- MACD
- DHT 0.02
- BHVN 0.26
- Stochastic Oscillator
- DHT 82.18
- BHVN 42.84
About DHT DHT Holdings Inc.
DHT Holdings Inc is a crude oil tanker company. It is an independent crude oil tanker company. Its fleet trades internationally and consists of crude oil tankers in the VLCC. It generates revenues from time charter and spot market operations. Its fleets consist of very large crude carriers known as VLCCs that range in size from 270,000 to 320,000 deadweight tons. Geographically, DHT operates in Monaco, Oslo, Norway, and Singapore. The company generates the majority of its revenue from the shipping revenues.
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.